The FDA is conducting market research to identify small business sources capable of providing a "Brand Name or Equal" Nanalysis AUTOsample-100 autosampler for use with an existing NMR system in Saint Louis, MO. The autosampler must be fully compatible with the government-owned Nanalysis 100-PRO benchtop NMR system and meet specific minimum technical requirements, including automated sample queuing and processing without operator intervention. Delivery of the newly manufactured, turn-key system must occur within 60 calendar days from the date of award, with installation and on-site training provided at the FDA facility in St. Louis, MO. Responses to this sources sought notice are due by May 26, 2026, at 1:00 PM Central Time, and must demonstrate the respondent's capability to provide the specified product or an equal alternative. No budget amount is specified, and this notice is for market research only, not a solicitation for proposals.